Iguana Healthcare Management’s Celgene Corp CELG Stock Holding History

Iguana Healthcare Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-75,000	Closed	-$7.83M	–	86
2017 Q4	$7.83M	Hold	75,000	–	–	5.1%	2
2017 Q3	$10.9M	Sell	75,000 -22,500	-23%	-$3.06M	5.96%	1
2017 Q2	$12.7M	Buy	97,500 +7,500	+8%	+$919K	7.16%	1
2017 Q1	$11.2M	Buy	90,000 +10,000	+13%	+$1.2M	5.54%	3
2016 Q4	$9.26M	Sell	80,000 -70,000	-47%	-$7.8M	5.53%	4
2016 Q3	$15.7M	Buy	150,000 +25,000	+20%	+$2.71M	2.8%	10
2016 Q2	$12.3M	Sell	125,000 -50,000	-29%	-$5.17M	5.02%	1
2016 Q1	$17.5M	Sell	175,000 -25,000	-13%	-$2.57M	6.42%	1
2015 Q4	$24M	Buy	200,000 +110,000	+122%	+$12.7M	7.88%	2
2015 Q3	$9.73M	Sell	90,000 -60,000	-40%	-$7.45M	3.83%	7
2015 Q2	$17.4M	Buy	150,000 +40,000	+36%	+$4.57M	5.48%	3
2015 Q1	$12.7M	Hold	110,000	–	–	5.33%	3
2014 Q4	$12.3M	Buy	110,000 +35,000	+47%	+$3.69M	5.95%	2
2014 Q3	$7.11M	Sell	75,000 -30,000	-29%	-$2.71M	3.8%	6
2014 Q2	$9.02M	Buy	+105,000	New	+$7.98M	4.21%	5

Other funds holding CELG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Iguana Healthcare Management's CELG Position: Q1 2018 in Review

Iguana Healthcare Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 75,000 shares — an estimated $7.83M sold.

Iguana Healthcare Management first reported a position in CELG in Q2 2014 and held it in 15 quarters. The position peaked at $24M in Q4 2015. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Iguana Healthcare Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
Iguana Healthcare Management sold 75,000 Celgene Corp shares in Q1 2018, an estimated $7.83M.
Iguana Healthcare Management first reported a position in Celgene Corp in Q2 2014 and held it in 15 quarters.
Iguana Healthcare Management's Celgene Corp position peaked at $24M in Q4 2015.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.